Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)

NCT00472953 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

38

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description

Conditions

Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: inhaled human insulin
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S